AAPL287.68+5.94 (+2.11%) ▲|ABBV251.31-3.00 (-1.18%) ▼|ABT90.94-1.77 (-1.91%) ▼|ACN124.80+0.06 (+0.05%) ▲|ADBE204.94-1.50 (-0.72%) ▼|AMAT737.76+43.12 (+6.21%) ▲|AMD582.51+43.02 (+7.97%) ▲|AMGN362.38+1.83 (+0.51%) ▲|AMT164.73-3.94 (-2.34%) ▼|AMZN237.74-2.40 (-1.00%) ▼|AVGO378.85+6.40 (+1.72%) ▲|AXP339.50-1.39 (-0.41%) ▼|BA215.84+1.15 (+0.54%) ▲|BAC57.06-0.83 (-1.43%) ▼|BKNG178.20-4.21 (-2.31%) ▼|BLK960.00+9.83 (+1.03%) ▲|BMY57.87-0.69 (-1.18%) ▼|BNY144.79+0.99 (+0.69%) ▲|BRK-B499.25+3.25 (+0.66%) ▲|C139.80-2.69 (-1.89%) ▼|CAT1,065.48+32.29 (+3.13%) ▲|CL91.57-0.83 (-0.90%) ▼|CMCSA24.46+0.24 (+0.97%) ▲|COF201.29-0.99 (-0.49%) ▼|COP103.99-0.21 (-0.20%) ▼|COST934.68-12.00 (-1.27%) ▼|CRM157.26-0.67 (-0.42%) ▼|CSCO117.52-0.18 (-0.15%) ▼|CVS103.91+0.33 (+0.32%) ▲|CVX166.05-2.43 (-1.44%) ▼|DE633.53+8.52 (+1.36%) ▲|DHR191.06-1.72 (-0.89%) ▼|DIS96.48-1.40 (-1.43%) ▼|DUK127.37-0.97 (-0.75%) ▼|EMR143.27+0.45 (+0.32%) ▲|FDX312.12-13.28 (-4.08%) ▼|GD354.24+6.17 (+1.77%) ▲|GE372.51-1.21 (-0.32%) ▼|GEV1,172.02+69.51 (+6.30%) ▲|GILD126.34+0.01 (+0.01%) ▲|GM77.10-0.24 (-0.31%) ▼|GOOG353.94+2.66 (+0.76%) ▲|GOOGL357.21+3.56 (+1.01%) ▲|GS1,012.89-7.32 (-0.72%) ▼|HD353.01+2.20 (+0.63%) ▲|HON221.55-6.25 (-2.74%) ▼|IBM282.10+4.10 (+1.47%) ▲|INTC140.61+8.89 (+6.75%) ▲|INTU261.52-4.88 (-1.83%) ▼|ISRG399.51-6.46 (-1.59%) ▼|JNJ254.93-3.59 (-1.39%) ▼|JPM327.10-2.29 (-0.70%) ▼|KO81.13-1.52 (-1.84%) ▼|LIN518.90+7.84 (+1.53%) ▲|LLY1,206.97-22.96 (-1.87%) ▼|LMT509.05+6.98 (+1.39%) ▲|LOW220.66+1.01 (+0.46%) ▲|LRCX436.60+25.69 (+6.25%) ▲|MA513.44+3.80 (+0.75%) ▲|MCD270.33+3.15 (+1.18%) ▲|MDLZ57.83-2.32 (-3.86%) ▼|MDT78.50-2.44 (-3.01%) ▼|META560.70-1.91 (-0.34%) ▼|MMM162.02-0.42 (-0.26%) ▼|MO72.03-2.02 (-2.73%) ▼|MRK128.44-0.95 (-0.73%) ▼|MS209.35-2.37 (-1.12%) ▼|MSFT371.19+2.62 (+0.71%) ▲|MU1,162.07+16.79 (+1.47%) ▲|NEE88.09-0.57 (-0.64%) ▼|NFLX71.87-1.91 (-2.59%) ▼|NKE41.17-0.31 (-0.76%) ▼|NOW99.31-0.66 (-0.66%) ▼|NVDA198.69+3.72 (+1.91%) ▲|ORCL147.31-0.45 (-0.30%) ▼|PEP135.20-3.49 (-2.51%) ▼|PFE24.10-0.28 (-1.13%) ▼|PG146.35-2.10 (-1.41%) ▼|PLTR116.58+0.88 (+0.76%) ▲|PM180.71-2.16 (-1.18%) ▼|QCOM184.23-4.49 (-2.38%) ▼|RTX189.60+2.27 (+1.21%) ▲|SBUX102.17-1.90 (-1.82%) ▼|SCHW92.12+1.57 (+1.73%) ▲|SO96.20-0.55 (-0.57%) ▼|SPG224.14-3.43 (-1.51%) ▼|T20.65-1.18 (-5.39%) ▼|TMO503.65-2.77 (-0.55%) ▼|TMUS167.70-6.28 (-3.61%) ▼|TSLA421.79+9.95 (+2.42%) ▲|TXN299.68+14.20 (+4.97%) ▲|UBER72.17-3.34 (-4.42%) ▼|UNH416.17-3.66 (-0.87%) ▼|UNP271.92-0.78 (-0.29%) ▼|UPS107.49-0.52 (-0.48%) ▼|USB60.57-0.20 (-0.32%) ▼|V343.09+1.44 (+0.42%) ▲|VZ42.32-1.79 (-4.05%) ▼|WFC82.79-0.72 (-0.86%) ▼|WMT113.08-1.52 (-1.33%) ▼|XOM136.52+0.46 (+0.33%) ▲|AAPL287.68+5.94 (+2.11%) ▲|ABBV251.31-3.00 (-1.18%) ▼|ABT90.94-1.77 (-1.91%) ▼|ACN124.80+0.06 (+0.05%) ▲|ADBE204.94-1.50 (-0.72%) ▼|AMAT737.76+43.12 (+6.21%) ▲|AMD582.51+43.02 (+7.97%) ▲|AMGN362.38+1.83 (+0.51%) ▲|AMT164.73-3.94 (-2.34%) ▼|AMZN237.74-2.40 (-1.00%) ▼|AVGO378.85+6.40 (+1.72%) ▲|AXP339.50-1.39 (-0.41%) ▼|BA215.84+1.15 (+0.54%) ▲|BAC57.06-0.83 (-1.43%) ▼|BKNG178.20-4.21 (-2.31%) ▼|BLK960.00+9.83 (+1.03%) ▲|BMY57.87-0.69 (-1.18%) ▼|BNY144.79+0.99 (+0.69%) ▲|BRK-B499.25+3.25 (+0.66%) ▲|C139.80-2.69 (-1.89%) ▼|CAT1,065.48+32.29 (+3.13%) ▲|CL91.57-0.83 (-0.90%) ▼|CMCSA24.46+0.24 (+0.97%) ▲|COF201.29-0.99 (-0.49%) ▼|COP103.99-0.21 (-0.20%) ▼|COST934.68-12.00 (-1.27%) ▼|CRM157.26-0.67 (-0.42%) ▼|CSCO117.52-0.18 (-0.15%) ▼|CVS103.91+0.33 (+0.32%) ▲|CVX166.05-2.43 (-1.44%) ▼|DE633.53+8.52 (+1.36%) ▲|DHR191.06-1.72 (-0.89%) ▼|DIS96.48-1.40 (-1.43%) ▼|DUK127.37-0.97 (-0.75%) ▼|EMR143.27+0.45 (+0.32%) ▲|FDX312.12-13.28 (-4.08%) ▼|GD354.24+6.17 (+1.77%) ▲|GE372.51-1.21 (-0.32%) ▼|GEV1,172.02+69.51 (+6.30%) ▲|GILD126.34+0.01 (+0.01%) ▲|GM77.10-0.24 (-0.31%) ▼|GOOG353.94+2.66 (+0.76%) ▲|GOOGL357.21+3.56 (+1.01%) ▲|GS1,012.89-7.32 (-0.72%) ▼|HD353.01+2.20 (+0.63%) ▲|HON221.55-6.25 (-2.74%) ▼|IBM282.10+4.10 (+1.47%) ▲|INTC140.61+8.89 (+6.75%) ▲|INTU261.52-4.88 (-1.83%) ▼|ISRG399.51-6.46 (-1.59%) ▼|JNJ254.93-3.59 (-1.39%) ▼|JPM327.10-2.29 (-0.70%) ▼|KO81.13-1.52 (-1.84%) ▼|LIN518.90+7.84 (+1.53%) ▲|LLY1,206.97-22.96 (-1.87%) ▼|LMT509.05+6.98 (+1.39%) ▲|LOW220.66+1.01 (+0.46%) ▲|LRCX436.60+25.69 (+6.25%) ▲|MA513.44+3.80 (+0.75%) ▲|MCD270.33+3.15 (+1.18%) ▲|MDLZ57.83-2.32 (-3.86%) ▼|MDT78.50-2.44 (-3.01%) ▼|META560.70-1.91 (-0.34%) ▼|MMM162.02-0.42 (-0.26%) ▼|MO72.03-2.02 (-2.73%) ▼|MRK128.44-0.95 (-0.73%) ▼|MS209.35-2.37 (-1.12%) ▼|MSFT371.19+2.62 (+0.71%) ▲|MU1,162.07+16.79 (+1.47%) ▲|NEE88.09-0.57 (-0.64%) ▼|NFLX71.87-1.91 (-2.59%) ▼|NKE41.17-0.31 (-0.76%) ▼|NOW99.31-0.66 (-0.66%) ▼|NVDA198.69+3.72 (+1.91%) ▲|ORCL147.31-0.45 (-0.30%) ▼|PEP135.20-3.49 (-2.51%) ▼|PFE24.10-0.28 (-1.13%) ▼|PG146.35-2.10 (-1.41%) ▼|PLTR116.58+0.88 (+0.76%) ▲|PM180.71-2.16 (-1.18%) ▼|QCOM184.23-4.49 (-2.38%) ▼|RTX189.60+2.27 (+1.21%) ▲|SBUX102.17-1.90 (-1.82%) ▼|SCHW92.12+1.57 (+1.73%) ▲|SO96.20-0.55 (-0.57%) ▼|SPG224.14-3.43 (-1.51%) ▼|T20.65-1.18 (-5.39%) ▼|TMO503.65-2.77 (-0.55%) ▼|TMUS167.70-6.28 (-3.61%) ▼|TSLA421.79+9.95 (+2.42%) ▲|TXN299.68+14.20 (+4.97%) ▲|UBER72.17-3.34 (-4.42%) ▼|UNH416.17-3.66 (-0.87%) ▼|UNP271.92-0.78 (-0.29%) ▼|UPS107.49-0.52 (-0.48%) ▼|USB60.57-0.20 (-0.32%) ▼|V343.09+1.44 (+0.42%) ▲|VZ42.32-1.79 (-4.05%) ▼|WFC82.79-0.72 (-0.86%) ▼|WMT113.08-1.52 (-1.33%) ▼|XOM136.52+0.46 (+0.33%) ▲|
31.4 C
New York
Tuesday, June 30, 2026

Tag: study

newssourceFORcompanyinformationcontent1releasesmarket

PEPGEN ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against PepGen, Inc. and Encourages Investors to Contact...

NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against PepGen, Inc. (“PepGen” or the “Company”) (NASDAQ: PEPG) in the United States District Court for the Eastern District of New York on behalf of all persons and entities who purchased or otherwise acquired PepGen securities between March 7, 2024 and March 3, 2025, both dates inclusive (the “Class Period”). Investors have until August 8, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Rocket Pharmaceuticals, Inc. Securities...

NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:

ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PEPG

NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of PepGen Inc. (NASDAQ: PEPG) between March 7, 2024 and March 3, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 8, 2025.

Multiple Sclerosis Market to Grow Rapidly at a CAGR of 3.8% During the Forecast Period (2025-2034) | DelveInsight

The multiple sclerosis market is growing due to rising prevalence, earlier diagnosis, and wider access to care. Demand is fueled by advancements in DMTs...

Alvotech’s Private Placement Completed with Delivery of SDRs and Shares to Investors

Alvotech (NASDAQ: ALVO, ALVO-SDB, the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the completion of a private placement that was carried out on June 4, 2025, directed to Swedish and international institutional investors. About 40 institutional investors participated in the placement. About 60% of the demand came from institutional investors based in Sweden, Norway or the UK, and about 30% from US-based funds. Over 80% of the shares and Swedish Depositary Receipts (SDRs) allocated in the placement, were sold to investors that were not previously shareholders in Alvotech.

Alvotech’s Private Placement Completed with Delivery of SDRs and Shares to Investors

Alvotech (NASDAQ: ALVO, ALVO-SDB, the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the completion of a private placement that was carried out on June 4, 2025, directed to Swedish and international institutional investors. About 40 institutional investors participated in the placement. About 60% of the demand came from institutional investors based in Sweden, Norway or the UK, and about 30% from US-based funds. Over 80% of the shares and Swedish Depositary Receipts (SDRs) allocated in the placement, were sold to investors that were not previously shareholders in Alvotech.

Intensity Therapeutics, Inc. Announces Proposed Public Offering of Common Stock

SHELTON, Conn., June 11, 2025 /PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or the "Company"), a late-stage clinical biotechnology company focused on the...

Insmed Announces Proposed $650 Million Public Offering of Common Stock

BRIDGEWATER, N.J., June 11, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to...

Shareholders who lost money on PepGen Inc. (NASDAQ: PEPG) Should Contact Wolf Haldenstein

NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- June 11, 2025 - Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed on behalf of all investors who purchased or otherwise acquired securities of PepGen Inc. (NASDAQ: PEPG) between March 7, 2024 and March 3, 2025, inclusive (the “Class Period”).

Dr. Hazem Afifi Launches Scholarship to Support the Next Generation of Medical Students

LAS VEGAS, June 11, 2025 (GLOBE NEWSWIRE) -- A new scholarship opportunity is now available to help undergraduate students pursuing careers in medicine achieve their academic and professional goals. The Dr. Hazem Afifi Scholarship for Medical Students has been established by renowned physician Dr. Hazem Afifi to provide meaningful financial support and recognition to dedicated medical students across the United States.

WCG CenterWatch Celebrates Excellence in Clinical Trial Collaborations with Inaugural Pinnacle Award for Site Relationships

CARY, N.C., June 11, 2025 /PRNewswire/ -- WCG, a global leader in providing solutions that measurably improve and accelerate clinical research, proudly announces the...

WELLA PROFESSIONALS NAMED AS OFFICAL PARTNER OF F1 ACADEMY™

NEW YORK, June 11, 2025 /PRNewswire/ -- F1 ACADEMY™ today announced a global partnership with Wella Company, naming the No.1 salon colour brand in the...

BIMZELX® (bimekizumab-bkzx) Three-Year Data at EULAR 2025 Showed Lasting Efficacy and Control of Inflammation in Psoriatic Arthritis and Axial Spondyloarthritis

Sustained symptom relief in patients with psoriatic arthritis: Achievement of the stringent ACR50 endpoint was sustained at three years by 53.2% and 55.2% of patients...

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In PepGen To Contact Him Directly To Discuss Their Options

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsStudy

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers